• HSA recalled 'CuraLin advanced glucose support' because it contained undisclosed glibenclamide and metformin.
• The recalled supplement was marketed to support healthy blood glucose levels but posed health risks due to the undeclared drugs.
• Consumers are warned to stop taking the product immediately, and sellers face potential prosecution.

The Health Sciences Authority (HSA) in Singapore issued a recall for 'CuraLin advanced glucose support' on May 5, 2025, after tests revealed the supplement contained undeclared prescription-only antidiabetic medicines, specifically glibenclamide and metformin. The HSA has directed LYC Nutrihealth, the importer, to halt sales and recall the affected batches. This action was taken to protect public health, as the undeclared drugs can cause serious side effects, especially for diabetic patients or those taking other antidiabetic medications.

• What: Recall of 'CuraLin advanced glucose support' due to the presence of undeclared glibenclamide and metformin.
• Who: Health Sciences Authority (HSA), LYC Nutrihealth (importer), consumers, sellers, and diabetic patients.
• When: Recall announced on May 5, 2025; batches expire in September 2026.
• Where: Singapore; supplement imported from the United States; sold on local e-commerce platforms like Shopee and Lazada.

The HSA's recall of 'CuraLin advanced glucose support' highlights the dangers of unregulated health supplements. The presence of prescription-only drugs like glibenclamide and metformin poses significant risks to consumers, particularly those with diabetes who may be unknowingly overdosing on medication or experiencing adverse reactions. The HSA's swift action to recall the product and warn the public is crucial in preventing potential harm. The marketing of the supplement as a natural way to support blood glucose levels is misleading and potentially dangerous, as it may lead consumers to forgo proper medical treatment.

The recall of 'CuraLin advanced glucose support' serves as a reminder of the importance of verifying the safety and ingredients of health supplements. Consumers are urged to discontinue using the product and consult with their doctors if they experience any adverse effects. The HSA is actively working to remove the product from the market and will take stern action against sellers who continue to distribute it. This incident underscores the need for stricter regulation and oversight of the supplement industry to protect public health.